Cargando…
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma
Glioblastoma (GBM) resistance to therapy is the most common cause of tumor recurrence, which is ultimately fatal in 90% of the patients 5 years after initial diagnosis. A sub-population of tumor cells with stem-like properties, glioma stem cells (GSCs), is specifically endowed to resist or adapt to...
Autores principales: | Singer, E, Judkins, J, Salomonis, N, Matlaf, L, Soteropoulos, P, McAllister, S, Soroceanu, L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669764/ https://www.ncbi.nlm.nih.gov/pubmed/25590811 http://dx.doi.org/10.1038/cddis.2014.566 |
Ejemplares similares
-
HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation
por: Cobbs, Charles, et al.
Publicado: (2014) -
Human Cytomegalovirus Gene Expression in Long-Term Infected Glioma Stem Cells
por: Fiallos, Estefania, et al.
Publicado: (2014) -
Cytomegalovirus pp71 Protein Is Expressed in Human Glioblastoma and Promotes Pro-Angiogenic Signaling by Activation of Stem Cell Factor
por: Matlaf, Lisa A., et al.
Publicado: (2013) -
Tissues Harvested Using an Automated Surgical Approach Confirm Molecular Heterogeneity of Glioblastoma and Enhance Specimen's Translational Research Value
por: Zusman, Edie, et al.
Publicado: (2019) -
Cannabidiol inhibits RAD51 and sensitizes glioblastoma to temozolomide in multiple orthotopic tumor models
por: Soroceanu, Liliana, et al.
Publicado: (2022)